Bz-L-Phe-OH

Bz-L-Phe-OH is an N-benzyl (Bz) protected L-phenylalanine bearing a free carboxylic acid, combining a chiral amino acid stereocenter with a benzyl-protected amine functionality and a phenyl side chain. The molecule's aromatic benzyl group and phenylalanine ring provide hydrophobic, π-interaction-capable surfaces that can influence peptide conformation and binding-site recognition in downstream constructs. The free α-carboxylic acid enables straightforward activation for peptide coupling, while the N-protection strategy supports chemoselective transformations by minimizing undesired amide formation at the amino group during intermediate synthesis. The overall reactivity profile makes Bz-L-Phe-OH a chiral amino acid intermediate suited for protected amino acid chemistry and peptide building block preparation.

1. Peptide Synthesis

Bz-L-Phe-OH is applied in peptide synthesis workflows where an N-protected L-phenylalanine residue with a free carboxyl group serves as a coupling-ready building block. The stereochemically defined L-configuration at the α-carbon supports predictable amide bond formation while the benzyl-protected nitrogen remains inert under many coupling conditions, reducing side reactions. The carboxylic acid can be activated to form an acylating species for stepwise peptide assembly, enabling C-terminal incorporation of a phenylalanine unit into protected peptide chains. Downstream peptide analogs prepared from Bz-L-Phe-OH can then undergo further protection/deprotection sequences to access target sequences for biochemical research and synthetic methodology development.

2. Protected Amino Acid Chemistry

Bz-L-Phe-OH is suitable for protected amino acid synthesis and intermediate preparation in fine chemical and process chemistry contexts. The N-benzyl protection strategy provides a controllable amine masking approach, while the free α-carboxyl group allows selective conversion into activated esters, mixed anhydrides, or peptide-ready derivatives as part of a controlled synthetic route. The phenyl side chain remains chemically stable under typical protection-handling conditions, supporting reliable stereochemical retention through multiple manipulations. The resulting intermediates can be used to build longer protected amino acid sequences or to generate defined fragments for subsequent coupling, including routes where orthogonal protection planning depends on benzyl-group behavior.

3. SAR Studies

Bz-L-Phe-OH is employed in structure-activity relationship studies for preparing phenylalanine-containing peptide mimetics and analog libraries. The combination of a stereodefined L-phenylalanine core with an N-protected amide-forming handle supports systematic variation of chain length and terminal modifications during analog construction. The aromatic side chain can participate in hydrophobic and π-stacking interactions, making phenylalanine substitution patterns relevant for mapping binding preferences and conformational effects. Downstream derivatives produced via peptide coupling from Bz-L-Phe-OH can be routed into SAR panels where controlled stereochemistry and consistent functional group presentation are required for interpretable structure-property trends.

4. Bioconjugation Chemistry

Bz-L-Phe-OH can be applied in bioconjugation chemistry as a defined amino acid-derived intermediate for constructing aromatic, amide-linked linkers. The free carboxylic acid enables formation of activated intermediates that can be coupled to nucleophilic functional groups on biomolecules or affinity tags, while the N-protection helps maintain chemoselectivity during linker assembly. The phenylalanine-derived aromatic motif can influence local hydrophobicity and spacing, which may affect conjugate solubility and interaction profiles in labeling or immobilization workflows. The protected amino acid scaffold also supports downstream deprotection and conversion into final conjugation-ready forms used in chemical biology and biomolecule modification programs.

5. Pharmaceutical Intermediate Preparation

Bz-L-Phe-OH is relevant to pharmaceutical intermediate preparation where chiral amino acid derivatives are incorporated into peptide-like fragments and constrained scaffolds. The free carboxylic acid supports conversion into acylating intermediates used to assemble amide-containing structures, while the N-benzyl protection can be managed within protecting-group strategies that align with multi-step synthesis planning. The phenylalanine side chain provides a chemically robust aromatic element that can be retained through manufacturing-oriented sequences, supporting consistent fragment identity across batch synthesis. The compound therefore functions as a stereochemically defined input for downstream fine chemical synthesis of protected peptide intermediates and related drug-discovery building blocks.

6. Analytical Research Standards

Bz-L-Phe-OH is utilized in analytical research for generating reference materials and method development samples involving amino acid-derived protected intermediates. The defined stereochemistry and characteristic aromatic benzyl and phenyl signals can support chromatographic and spectrometric identification of phenylalanine-containing fragments during synthesis monitoring. The presence of a free carboxylic acid and an N-protected amine allows formation of derivatives that can be used to validate coupling steps, protection integrity, and deprotection endpoints in analytical workflows. The compound's structure supports reproducible preparation of standards for amino acid derivative quantification and impurity profiling in peptide and peptide-mimetic manufacturing development.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis